Kabakoff B, Lennarz W J
Department of Biochemistry and Molecular Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
J Cell Biol. 1990 Aug;111(2):391-400. doi: 10.1083/jcb.111.2.391.
Previous studies have implicated an 130-kD glycoprotein containing complex, N-linked oligosaccharide chain(s) in the process of spicule formation in sea urchin embryos. To ascertain whether the processing of high mannose oligosaccharides to complex oligosaccharides is necessary for spiculogenesis, intact embryos and cultures of spicule-forming primary mesenchyme cells were treated with glycoprotein processing inhibitors. In both the embryonic and cell culture systems 1-deoxymannojirimycin (1-MMN) and, to a lesser extent, 1-deoxynojirimycin (1-DNJ) inhibited spicule formation. These inhibitors did not affect gastrulation in whole embryos or filopodial network formation in cell cultures. Swainsonine (SWSN) and castanospermine (CSTP) had no effect in either system. Further analysis revealed the following: (a) 1-MMN entered the embryos and blocked glycoprotein processing in the 24-h period before spicule formation as assessed by a twofold increase in endoglycosidase H sensitivity among newly synthesized glycoproteins upon addition of 1-MMN; (b) 1-MMN did not affect general protein synthesis until after its effects on spicule formation were observed; (c) Immunoblot analysis with an antibody directed towards the polypeptide chain of the 130-kD protein (mAb A3) demonstrated that 1-MMN did not affect the level of the polypeptide that is known to be synthesized just before spicule formation; (d) 1-MMN and 1-DNJ almost completely abolished (greater than 95%) the appearance of mAb 1223 reactive complex oligosaccharide moiety associated with the 130-kD glycoprotein; CSTP and SWSN had much less of an effect on expression of this epitope. These results indicate that the conversion of high mannose oligosaccharides to complex oligosaccharides is required for spiculogenesis in sea urchin embryos and they suggest that the 130-kD protein is one of these essential complex glycoproteins.
先前的研究表明,一种含有复杂的、N-连接寡糖链的130-kD糖蛋白参与了海胆胚胎中骨针形成的过程。为了确定高甘露糖型寡糖加工成复杂型寡糖对于骨针形成是否必要,完整胚胎和形成骨针的原代间充质细胞培养物用糖蛋白加工抑制剂进行处理。在胚胎和细胞培养系统中,1-脱氧甘露基野尻霉素(1-MMN)以及在较小程度上1-脱氧野尻霉素(1-DNJ)均抑制骨针形成。这些抑制剂不影响整个胚胎的原肠胚形成或细胞培养中的丝状伪足网络形成。苦马豆素(SWSN)和栗精胺(CSTP)在任一系统中均无作用。进一步分析揭示了以下几点:(a)1-MMN进入胚胎,并在骨针形成前的24小时内阻断糖蛋白加工,这可通过添加1-MMN后新合成糖蛋白对内切糖苷酶H敏感性增加两倍来评估;(b)1-MMN在观察到其对骨针形成的影响之后才影响一般蛋白质合成;(c)用针对130-kD蛋白多肽链的抗体(单克隆抗体A3)进行免疫印迹分析表明,1-MMN不影响已知在骨针形成前合成的多肽水平;(d)1-MMN和1-DNJ几乎完全消除(大于95%)了与130-kD糖蛋白相关的单克隆抗体1223反应性复杂寡糖部分的出现;CSTP和SWSN对该表位的表达影响小得多。这些结果表明,高甘露糖型寡糖向复杂型寡糖的转化是海胆胚胎骨针形成所必需的,并且提示130-kD蛋白是这些必需的复杂糖蛋白之一。